FDA Approves Pivotal Trial for New Vasectomy Device

The FDA has approved an Investigational Device Exemption, allowing a pivotal trial to begin for the Signati Separo Vessel Sealing System. This energy-based platform is designed for vasectomy procedures. The trial will compare the Separo system to conventional methods, enrolling 120 adult male patients across U.S. clinical sites.